Extrapolation of midazolam disposition in neonates using physiological based pharmacokinetic/pharmacodynamic (PBPK/PD) modelling

Author:

Zhao Tangping1,Zhou Sufeng1,Wang Lu1,Li Tongtong1,Zhu Jinying1,Shao Feng1

Affiliation:

1. the First Affiliated Hospital with Nanjing Medical University

Abstract

Abstract Objective: To explore the feasibility of model simulation research strategies for dose optimization in the neonatal populations. Using midazolam as a model drug, a PBPK/PD model was established to simulated and optimize the dosing regimen for sedation in the neonatal population. Methods: Firstly, an adult PBPK/PD model was established. Secondly, the research strategy of extrapolating adult drug use data to newborns was applied. The adult PBPK/PD model was extrapolated to the neonatal population according to the maturation formula of plasma albumin and metabolic enzyme CYP3A4/5. The robustness of the neonatal model was evaluated using clinical data from different age stratification. The neonatal PBPK/PD model was then used to simulate the dosage regimen of midazolam for sedation in newborns. Results: Individualized validation in adults showed that 95.1% of the predicted concentration values were within two-fold, and all the predicted AUC values were within two-fold; the extrapolated neonatal model showed that about 84.4% of the predicted concentration values were within two-fold, the AAFE value of the overall model was < 2, and the AFE value was between 0.5–1.5; the validated neonatal PBPK/PD model showed that virtual term neonates maintained a target plasma concentration range within 26 hours when using the dosage regimen recommended on the product label (0.06 mg/kg/h, iv infusion 12 hours), the optimal dose for premature infants to reach the target plasma concentration range may need to be slightly higher than the recommended dose on the product label (0.03mg/kg/h, iv infusion 12h). Conclusion: We successfully established a neonatal PBPK/PD model of midazolam by referring to extrapolated-based research strategy and integrating the influence of human physiological development on drug disposal. Finally, the model was validated with the dosage of midazolam in the product specification, and reliable results were obtained.

Publisher

Research Square Platform LLC

Reference56 articles.

1. Preterm Physiologically Based Pharmacokinetic Model. Part II: Applications of the Model to Predict Drug Pharmacokinetics in the Preterm Population;Abduljalil K;Clin Pharmacokinet,2020

2. Administration USFD Physiologically Based Pharmacokinetic Analyses — Format and Content Guidance for Industry

3. ICH Topic E11 Clinical Investigation of Medicinal Products in the Paediatric Population;Agency EM,2017

4. Analgesia and sedation in preterm neonates who require ventilatory support - Results from the NOPAIN trial;Anand KJS;Arch Pediatr Adolesc Med,1999

5. Anderson BJ (2017) Pharmacokinetics and Pharmacodynamics in the Pediatric Population. In: Mason, MD, K.P. (eds) Pediatric Sedation Outside of the Operating Room

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3